circlepharma.com
Circle Pharma
http://www.circlepharma.com/team.php
The promise of macrocycles. Matthew P. Jacobson, PhD. Co-Founder and SAB Member. Matthew P. Jacobson, Ph.D. - Co-Founder and SAB Member. R Scott Lokey, PhD. Co-Founder and SAB Chairman. R Scott Lokey, Ph.D. - Co-Founder and SAB Chairman. David J. Earp, JD, PhD. David J. Earp, J.D., Ph.D. - President and CEO. Pablo D. Garcia, PhD. Director, Oncology Research. Pablo D. Garcia, Ph.D. - Director, Oncology Research. Mahesh Ramaseshan, PhD. Mahesh Ramaseshan, Ph.D. - Senior Principal Scientist. We are convenie...
circlepharma.com
Circle Pharma
http://www.circlepharma.com/our-pipeline.php
The promise of macrocycles. Circle is advancing a new paradigm in macrocycle drug discovery to develop intrinsically cell permeable macrocycles against important therapeutic targets. Our technology allows us to address therapeutic targets that are considered undruggable with small molecules or biologicals, in particular intracellular protein-protein interactions. This target class covers a wide range of therapeutic indications and includes many high value targets that have been biologically valid...We ar...
circlepharma.com
Circle Pharma
http://www.circlepharma.com/publications.php
The promise of macrocycles. Macrocycles in new drug discovery. Future Med Chem; J. Mallinson and I. Collins, 2012. Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties? J Med Chem; F. Giordanetto and J. Kihlberg; 2014. Science-Business eXchange collection entitled Macrocycles and constrained peptides . Published in April 2013, it offers an excellent overview of the macrocycle field. Publications by our team members. Med Chem Comm; A.C. Rand, S.S&#...On-resin ...
circlepharma.com
Circle Pharma
http://www.circlepharma.com/careers.php
The promise of macrocycles. We are looking for people with the right combination of intellect, talent and energy to help drive Circle Pharma’s development. At Circle, you will find the opportunity to work with innovative peptide design and chemistry technologies while experiencing the excitement, challenges and rewards of a startup environment. Research Associate - Analytical Chemistry. Research Associate - Analytical Chemistry. Generation of high quality calibration curves. Knowledge of analytical metho...
circlepharma.com
Circle Pharma
http://www.circlepharma.com/the-promise-of-macrocycles.php
The promise of macrocycles. The promise of macrocycles. The promise of macrocycles. 650 ) 392.0363. 280 Utah Avenue, Suite 100, South San Francisco, CA 94080-6883. Circle Pharma. 2014 - Design: Visualatin.
circlepharma.com
Circle Pharma
http://www.circlepharma.com/our-approach.php
The promise of macrocycles. Circle is taking a new approach to the development of macrocylic peptide therapeuticsthat is based on the pioneering work of its founders to understand and computationally predict drug-like properties of macrocycles. Circle is advancing this understanding to design novel, inherently permeable macrocyclic peptide drug candidates against Circle’s internal targets and those of our collaboration partners. The promise of macrocycles. 650 ) 392.0363.
circlepharma.com
Circle Pharma
http://www.circlepharma.com/investors.php
The promise of macrocycles. Working together for a healthier world. SHANGPHARMA INVESTMENT GROUP, LIMITED. With the mission of providing and developing cutting edge science and technology to help its partners develop important new therapies, the ShangPharma Group includes divisions wholly focused on enabling new technologies ('ShangPharma Technologies') and investing in early stage ideas ('ShangPharma Investments') that provide the innovative foundations for future drug therapies. 650 ) 392.0363.
circlepharma.com
Circle Pharma
http://www.circlepharma.com/our-partners.php
The promise of macrocycles. In June 2014, Circle entered into collaborations to develop permeable macrocyclic peptides against two Pfizer-nominated targets. Under the terms of each of the two collaboration agreements, Pfizer has the exclusive option to take exclusive rights to compounds identified in the collaborations. 650 ) 392.0363. 280 Utah Avenue, Suite 100, South San Francisco, CA 94080-6883. Circle Pharma. 2014 - Design: Visualatin.
circlepharma.com
Circle Pharma
http://www.circlepharma.com/board-of-directors.php
The promise of macrocycles. David J. Earp, JD, PhD. David J. Earp, J.D., Ph.D. - President and CEO. David received his B.Sc. (with first class honours) in microbiology from the University of Leeds, his Ph.D. in biochemistry and molecular biology from the University of Cambridge, and his J.D. (magna cum laude) from the Northwestern School of Law of Lewis and Clark College. He was a postdoctoral research fellow at the University of California, Berkeley / USDA PGEC. Douglas Crawford, PhD. R Scott Lokey, PhD.
SOCIAL ENGAGEMENT